Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Exemestane

Brand: 
NICE TA: 112
Indication: Hormonal treatment for early breast cancer (NICE TA112)
Disease category: Malignant Disease & Immunosuppression
Commissioning responsibility: CCG
PbR excluded: No

Background

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

NICE TA112 - Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancerĀ 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber 0

Amber 0